{"product_id":"novel-treatments-in-pediatric-2022","title":"Novel Treatments in Pediatric Hematopoietic Stem Cell Transplantation and Cellular Therapies 2022","description":"\u003ch4 class=\"activitysectionbold\"\u003eDate \u0026amp; Location\u003c\/h4\u003e\u003cbr\u003eWednesday, November 2, 2022, 7:50 AM - 5:40 PM, Online, New York, NY\u003cbr\u003e\u003ch4 class=\"activitysectionbold\"\u003eSpecialties\u003c\/h4\u003e\n\u003cdiv\u003e\n\u003cem\u003eSpecialties\u003c\/em\u003e - Bone Marrow Transplant\u003c\/div\u003e\n\u003ch4 class=\"activitysectionbold\"\u003eOverview\u003c\/h4\u003e\n\u003cstrong\u003eNovel Treatments in Pediatric Hematopoietic Stem Cell Transplantation and Cellular Therapies Hematopoietic stem cell transplant (HSCT) and cellular therapy is a hyper-specialized field within the already specialized pediatric oncology world. \u003c\/strong\u003eThis necessitates providers to stay current on the rapidly evolving science behind the care of these complex patients.\u003cbr\u003e\u003cbr\u003eThis one-day symposium will have a \u003cstrong\u003efocus on topics curated for advanced practice providers, including a mix of foundations of HSCT in addition to current clinical developments in the field. \u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eThe focused topics will include advances in GVHD therapies, unique disease processes that are being transplanted more often in the current era, diagnostic findings of HSCT complications, and new clinical trials that our patients are undergoing including JSP for SCID, TCR modified T-cell therapy for sarcoma patients and expanded cord blood transplant for multiply relapsed leukemia.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eWho Should Attend\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eThis symposium is intended for advanced practice providers who will be caring primarily or be involved in the care of pediatric hemopoietic stem cell transplant patients.\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eObjectives\u003c\/strong\u003e\u003c\/div\u003e\n\u003col\u003e\n\u003cli\u003eDiscuss the role of allogeneic hematopoietic stem transplantation in the treatment of both malignant and non-malignant diseases\u003c\/li\u003e\n\u003cli\u003eIdentify the how and why hematopoietic stem cell transplant conditioning regimens are selected\u003c\/li\u003e\n\u003cli\u003eDescribe the pathophysiology and clinical management of common hematopoietic stem cell transplant complications and toxicities\u003c\/li\u003e\n\u003cli\u003eGain knowledge of the new advancements in care of pediatric hematopoietic stem cell transplant patients, including new types of transplants and other alternatives such as gene therapy\u003c\/li\u003e\n\u003cli\u003eSummarize the mechanism of acute and chronic GVHD including prophylactic strategies, treatment (including new research based therapies) and supportive care\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eAdvances in Treatment of acute GVHD.mp4\u003c\/li\u003e\n\u003cli\u003eAdvances in Treatment of acute GVHD.pdf\u003c\/li\u003e\n\u003cli\u003eAPP-Peds-BMT-brochure.pdf\u003c\/li\u003e\n\u003cli\u003eBone Marrow Failure Syndromes Fanconi Anemia.mp4\u003c\/li\u003e\n\u003cli\u003eBone Marrow Failure Syndromes Fanconi Anemia.pdf\u003c\/li\u003e\n\u003cli\u003eComplications from HSCT Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003cli\u003eConditioning Regimens Graft Sources.mp4\u003c\/li\u003e\n\u003cli\u003eConditioning Regimens Graft Sources.pdf\u003c\/li\u003e\n\u003cli\u003eDermatology Presentation and Treatment Markova.mp4\u003c\/li\u003e\n\u003cli\u003eDermatology Presentation and Treatment Markova.pdf\u003c\/li\u003e\n\u003cli\u003eDermatology Presentation and Treatment Queliza.mp4\u003c\/li\u003e\n\u003cli\u003eDermatology Presentation and Treatment Queliza.pdf\u003c\/li\u003e\n\u003cli\u003eExpanded Cord Blood for Relapsed Leukemia.mp4\u003c\/li\u003e\n\u003cli\u003eExpanded Cord Blood for Relapsed Leukemia.pdf\u003c\/li\u003e\n\u003cli\u003eFoundations of Pediatric Hematopoetic Stem Cell Transplant (HSCT) and Cell Therapie.mp4\u003c\/li\u003e\n\u003cli\u003eFoundations of Pediatric Hematopoetic Stem Cell Transplant (HSCT) and Cell Therapie.pdf\u003c\/li\u003e\n\u003cli\u003eGraft Vs. Host Disease in the Pediatric HSCT Patient Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003cli\u003eHSCT for Epidermolysis Bullosa and Other Metabolic Syndromes.mp4\u003c\/li\u003e\n\u003cli\u003eHSCT for Epidermolysis Bullosa and Other Metabolic Syndromes.pdf\u003c\/li\u003e\n\u003cli\u003eJasper Antibody for SCID (Severe Compromised Immunodeficiency).mp4\u003c\/li\u003e\n\u003cli\u003eJasper Antibody for SCID (Severe Compromised Immunodeficiency).pdf\u003c\/li\u003e\n\u003cli\u003eNewest Clinical Trials Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003cli\u003ePatient Perspective – My life after Transplant.mp4\u003c\/li\u003e\n\u003cli\u003ePatient Perspective – My life after Transplant.pdf\u003c\/li\u003e\n\u003cli\u003ePost-Transplant Lymphoproliferative Disease (PTLD) and the use of EBV CTLs.mp4\u003c\/li\u003e\n\u003cli\u003ePost-Transplant Lymphoproliferative Disease (PTLD) and the use of EBV CTLs.pdf\u003c\/li\u003e\n\u003cli\u003ePulmonary GVHD Picture.mp4\u003c\/li\u003e\n\u003cli\u003ePulmonary GVHD Picture.pdf\u003c\/li\u003e\n\u003cli\u003eSickle Cell Disease.mp4\u003c\/li\u003e\n\u003cli\u003eSickle Cell Disease.pdf\u003c\/li\u003e\n\u003cli\u003eSinusoidal Obstructive Syndrome (SOS)- Radiographic Findings.mp4\u003c\/li\u003e\n\u003cli\u003eSinusoidal Obstructive Syndrome (SOS)- Radiographic Findings.pdf\u003c\/li\u003e\n\u003cli\u003eStarting with Basics Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003cli\u003eTCR-modified T-cell Therapy.mp4\u003c\/li\u003e\n\u003cli\u003eTCR-modified T-cell Therapy.pdf\u003c\/li\u003e\n\u003cli\u003eTransplant Associated Thrombotic Microangiopathy (TMA).mp4\u003c\/li\u003e\n\u003cli\u003eTransplant Associated Thrombotic Microangiopathy (TMA).pdf\u003c\/li\u003e\n\u003cli\u003eTransplant for Nonmalignant Diseases Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954386145378,"sku":"MED-AMB02384","price":20.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Navigating-Novel-Treatments-in-Pediatric-Hematopoietic-Stem-Cell-Transplantation-and-Cellular-Therapies-2022.jpg?v=1779375092","url":"https:\/\/meducourse.com\/products\/novel-treatments-in-pediatric-2022","provider":"Meducourse","version":"1.0","type":"link"}